Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page shows a minor version update from v3.3.1 to v3.3.2 with no substantive changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page now notes that publications are automatically filled from PubMed and the page revision is updated to v3.3.1; the previous PubMed note and Revision v3.2.0 have been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the funding-lapse notice and the associated government operating-status guidance from the page.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedNo significant changes detected in the study details or site listings. The information presented remains consistent with the page’s purpose and does not affect enrollment or understanding.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a government funding notice and current operating status guidance (and updated the version to v3.2.0), replacing the previous v3.1.0.SummaryDifference0.9%

- Check71 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.SummaryDifference0.0%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.